Abstract
Background The complexity of sleep hinders the formulation of sleep guidelines. Recent studies suggest that different unhealthy sleep characteristics jointly increase the risks for cardiovascular disease (CVD). This study aimed to estimate the differences in CVD-free life expectancy between people with different sleep profiles.
Methods We included 308683 middle-aged adults from the UK Biobank among whom 140181 had primary care data linkage. We used an established composite sleep score comprising self-reported chronotype, duration, insomnia complaints, snoring, and daytime sleepiness to derive three sleep categories: poor, intermediate, and healthy. We also identified three clinical sleep disorders captured by primary care and inpatient records within two years before enrollment in the cohort: insomnia, sleep-related breathing disorders, and other sleep disorders. We estimated sex-specific CVD-free life expectancy with three-state Markov models conditioning on survival at age 40 across different sleep profiles and clinical disorders.
Results We observed a gradual loss in CVD-free life expectancy toward poor sleep such as, compared with healthy sleepers, poor sleepers lost 1·80 [95% CI 0·96-2·75] and 2·31 [1·46-3·29] CVD-free years in females and males, respectively, while intermediate sleepers lost 0·48 [0·41-0·55] and 0·55 [0·49-0·61] years. Among men, those with clinical insomnia or sleep-related breathing disorders lost CVD-free life by 3·84 [0·61-8·59] or 6·73 [5·31-8·48] years, respectively. Among women, sleep-related breathing disorders or other sleep disorders were associated with 7·32 [5·33-10·34] or 1·43 [0·20-3·29] years lost, respectively.
Conclusions Both self-reported and doctor-diagnosed poor sleep are negatively associated with CVD-free life, especially pronounced in participants with sleep-related breathing disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
BH is a PhD student supported by the Taiwanese Ministry of Education and the University of Sydney. ES is funded by the Australian National Health and Medical Research Council through an Investigator Grant Level 2 (APP1180812). No conflict of interest was declared as the funding sources had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The National Health Service and the National Research Ethics Service have approved the UK Biobank (Ref. 11/NW/0382) while all participants gave written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the UK Biobank but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of the UK Biobank.
List of Abbreviations
- BMI
- Body Mass Index
- BNF
- British National Formulary
- CTV3
- Clinical Terms Version 3
- CVD
- Cardiovascular Disease
- dm+d
- Dictionary of Medicines and Devices
- HR
- Hazard Ratios
- ICD
- International Classification of Diseases
- NHS
- National Health Service
- Read v2
- Read codes version 2
